AAV病毒包装
研选

AAV病毒包装

收藏
  • 询价
  • 派真生物提供高效、快速、稳定、可靠的AAV病毒产品。
  • 广州市
  • 2025年12月23日
    48h发货
    24h回复
    售后服务
    技术支持
    文献支持
    avatar
    广州派真生物技术有限公司
    8 年钻石会员

  • 企业认证

    • 研选banner

    快至6-9个工作日，80多种血清型，滴度经标准品校正，高纯度，为您的实验保驾护航

    研选同类产品更多 >

    万千商家帮你免费找货

    0 人在求购买到急需产品
    • 详细信息
    • 用户评价
    • 文献和实验
    • 技术资料
    • 提供商：

      派真生物

    • 服务名称：

      病毒包装服务

    派真服务
    派真生物致力于为客户提供行业领先的腺相关病毒（AAV）包装服务。凭借我们专有的高产生产技术平台，优化的细胞系以及增强的RC和辅助质粒，我们能够最大限度地提高病毒产量。经过十逾年的项目经验积累和技术创新，我们已经成功生产了90多种血清型AAV产品，以高滴度、高纯度、高效力和高度一致性获得了广大客户的信赖。
     
    除了提供用于临床前研究的科研级、非人灵长类动物（NHP）级和高通量HT级AAV载体外，我们还提供符合良好生产管理规范（GMP）标准的AAV生产服务，以支持临床应用。

    AAV病毒包装

     

    关键优势

    • 快速交付: 5E+13 GC以内可在6~9个工作日交付
    • 质量可靠: AAV滴度≥1E+13 GC/mL，AAV纯度≥95%以上，空壳率可低至1%
    • 全面的分析: 可选择HPLC、电镜、支原体、rcAAV、TCID50等几十项检测项目
    • 血清型丰富：可提供90+不同的AAV血清型，覆盖大脑、心脏、眼睛、肌肉、肝脏、肺脏、肾脏等多种组织器官
    • 经验丰富: 10+年专业AAV生产经验，成功交付20,000+批次AAV病毒
    • 载体设计支持: “派载体”线上设计平台及博士级技术支持
     

    服务明细

    AAV病毒包装

    AAV病毒包装

    产品性能

    AAV病毒包装

    更多服务相关信息，请留言咨询！ 

    风险提示：丁香通仅作为第三方平台，为商家信息发布提供平台空间。用户咨询产品时请注意保护个人信息及财产安全，合理判断，谨慎选购商品，商家和用户对交易行为负责。对于医疗器械类产品，请先查证核实企业经营资质和医疗器械产品注册证情况。

    图标用户评价
      图标暂无用户评价
      图标文献和实验
      该产品被引用文献
      客户发表文献（部分）：
      1. Yi Z, Qu L, Tang H, Liu Z, Liu Y, Tian F, Wang C, Zhang X, Feng Z, Yu Y, Yuan P, Yi Z, Zhao Y, Wei W. Engineered circular ADAR-recruiting RNAs increase the efficiency and fidelity of RNA editing in vitro and in vivo. Nat Biotechnol. 2022 Jun;40(6):946-955. doi: 10.1038/s41587-021-01180-3. Epub 2022 Feb 10. PMID: 35145313.
      2. Li Z, Peng M, Chen P, Liu C, Hu A, Zhang Y, Peng J, Liu J, Li Y, Li W, Zhu W, Guan D, Zhang Y, Chen H, Li J, Fan D, Huang K, Lin F, Zhang Z, Guo Z, Luo H, He X, Zhu Y, Li L, Huang B, Cai W, Gu L, Lu Y, Deng K, Yan L, Chen S. Imatinib and methazolamide ameliorate COVID-19-induced metabolic complications via elevating ACE2 enzymatic activity and inhibiting viral entry. Cell Metab. 2022 Mar 1;34(3):424-440.e7. doi: 10.1016/j.cmet.2022.01.008. Epub 2022 Feb 11. PMID: 35150639; PMCID: PMC8832557.
      3. Guan R, Yuan L, Li J, Wang J, Li Z, Cai Z, Guo H, Fang Y, Lin R, Liu W, Wang L, Zheng Q, Xu J, Zhou Y, Qian J, Ding M, Luo J, Li Y, Yang K, Sun D, Yao H, He J, Lu W. Bone morphogenetic protein 4 inhibits pulmonary fibrosis by modulating cellular senescence and mitophagy in lung fibroblasts. Eur Respir J. 2022 Dec 15;60(6):2102307. doi: 10.1183/13993003.02307-2021. PMID: 35777761; PMCID: PMC9808813.
      4. Guo B, Chen J, Chen Q, Ren K, Feng D, Mao H, Yao H, Yang J, Liu H, Liu Y, Jia F, Qi C, Lynn-Jones T, Hu H, Fu Z, Feng G, Wang W, Wu S. Anterior cingulate cortex dysfunction underlies social deficits in Shank3 mutant mice. Nat Neurosci. 2019 Aug;22(8):1223-1234. doi: 10.1038/s41593-019-0445-9. Epub 2019 Jul 22. PMID: 31332372.
      5. Moghadam F, LeGraw R, Velazquez JJ, Yeo NC, Xu C, Park J, Chavez A, Ebrahimkhani MR, Kiani S. Synthetic immunomodulation with a CRISPR super-repressor in vivo. Nat Cell Biol. 2020 Sep;22(9):1143-1154. doi: 10.1038/s41556-020-0563-3. Epub 2020 Sep 3. PMID: 32884147; PMCID: PMC7480217.
      6. Wang L, Xue W, Zhang H, Gao R, Qiu H, Wei J, Zhou L, Lei YN, Wu X, Li X, Liu C, Wu J, Chen Q, Ma H, Huang X, Cai C, Zhang Y, Yang B, Yin H, Yang L, Chen J. Eliminating base-editor-induced genome-wide and transcriptome-wide off-target mutations. Nat Cell Biol. 2021 May;23(5):552-563. doi: 10.1038/s41556-021-00671-4. Epub 2021 May 10. PMID: 33972728.
      7. Daniel HD, Kumar S, Kannangai R, J F, Joel JN, Abraham A, Lakshmi KM, Agbandje-McKenna M, Coleman KE, Srivastava A, Srivastava A, Abraham AM. Age-stratified adeno-associated virus serotype 3 neutralizing and total antibody prevalence in hemophilia A patients from India. J Med Virol. 2022 Sep;94(9):4542-4547. doi: 10.1002/jmv.27859. Epub 2022 May 31. PMID: 35577570.
      8. Xiao Q, Xu Z, Xue Y, Xu C, Han L, Liu Y, Wang F, Zhang R, Han S, Wang X, Li GL, Li H, Yang H, Shu Y. Rescue of autosomal dominant hearing loss by in vivo delivery of mini dCas13X-derived RNA base editor. Sci Transl Med. 2022 Jul 20;14(654):eabn0449. doi: 10.1126/scitranslmed.abn0449. Epub 2022 Jul 20. PMID: 35857824.
      9. Yang Y, Peng Y, Lin C, Long L, Hu J, He J, Zeng H, Huang Z, Li ZY, Tanemura M, Shi J, Lombardi JR, Luo X. Human ACE2-Functionalized Gold "Virus-Trap" Nanostructures for Accurate Capture of SARS-CoV-2 and Single-Virus SERS Detection. Nanomicro Lett. 2021 Apr 13;13:109. doi: 10.1007/s40820-021-00620-8. PMID: 33868761; PMCID: PMC8042470.
      10. Xu Y, Zhou Z, Kang X, Pan L, Liu C, Liang X, Chu J, Dong S, Li Y, Liu Q, Sun Y, Yu S, Zhang Q. Mettl3-mediated mRNA m6A modification controls postnatal liver development by modulating the transcription factor Hnf4a. Nat Commun. 2022 Aug 5;13(1):4555. doi: 10.1038/s41467-022-32169-4. PMID: 35931692; PMCID: PMC9355946.
      11. Zhang R, Xu G, Cao L, Sun Z, He Y, Cui M, Sun Y, Li S, Li H, Qin L, Hu M, Yuan Z, Rao Z, Ding W, Rao Z, Lou Z. Divergent engagements between adeno-associated viruses with their cellular receptor AAVR. Nat Commun. 2019 Aug 21;10(1):3760. doi: 10.1038/s41467-019-11668-x. PMID: 31434885; PMCID: PMC6704107.
      12. Huang Y, Zhang H, Wang L, Tang C, Qin X, Wu X, Pan M, Tang Y, Yang Z, Babarinde IA, Lin R, Ji G, Lai Y, Xu X, Su J, Wen X, Satoh T, Ahmed T, Malik V, Ward C, Volpe G, Guo L, Chen J, Sun L, Li Y, Huang X, Bao X, Gao F, Liu B, Zheng H, Jauch R, Lai L, Pan G, Chen J, Testa G, Akira S, Hu J, Pei D, Hutchins AP, Esteban MA, Qin B. JMJD3 acts in tandem with KLF4 to facilitate reprogramming to pluripotency. Nat Commun. 2020 Oct 8;11(1):5061. doi: 10.1038/s41467-020-18900-z. PMID: 33033262; PMCID: PMC7545202.
      13. Chen M, Shi H, Gou S, Wang X, Li L, Jin Q, Wu H, Zhang H, Li Y, Wang L, Li H, Lin J, Guo W, Jiang Z, Yang X, Xu A, Zhu Y, Zhang C, Lai L, Li X. In vivo genome editing in mouse restores dystrophin expression in Duchenne muscular dystrophy patient muscle fibers. Genome Med. 2021 Apr 12;13(1):57. doi: 10.1186/s13073-021-00876-0. PMID: 33845891; PMCID: PMC8042958.
      14. Wu Z, Zhang Y, Yu H, Pan D, Wang Y, Wang Y, Li F, Liu C, Nan H, Chen W, Ji Q. Programmed genome editing by a miniature CRISPR-Cas12f nuclease. Nat Chem Biol. 2021 Nov;17(11):1132-1138. doi: 10.1038/s41589-021-00868-6. Epub 2021 Sep 2. PMID: 34475565.
      15. Riedmayr LM, Hinrichsmeyer KS, Karguth N, Böhm S, Splith V, Michalakis S, Becirovic E. dCas9-VPR-mediated transcriptional activation of functionally equivalent genes for gene therapy. Nat Protoc. 2022 Mar;17(3):781-818. doi: 10.1038/s41596-021-00666-3. Epub 2022 Feb 7. PMID: 35132255.
      16. Shi X, Wang Z, Ren W, Chen L, Xu C, Li M, Fan S, Xu Y, Chen M, Zheng F, Zhang W, Zhou X, Zhang Y, Qiu S, Wu L, Zhou P, Lv X, Cui T, Qiao Y, Zhao H, Guo W, Chen W, Li S, Zhong W, Lin J, Yang S. LDL receptor-related protein 1 (LRP1), a novel target for opening the blood-labyrinth barrier (BLB). Signal Transduct Target Ther. 2022 Jun 10;7(1):175. doi: 10.1038/s41392-022-00995-z. PMID: 35680846; PMCID: PMC9184653.
      17. Qiu Y, Cheng R, Liang C, Yao Y, Zhang W, Zhang J, Zhang M, Li B, Xu C, Zhang R. MicroRNA-20b Promotes Cardiac Hypertrophy by the Inhibition of Mitofusin 2-Mediated Inter-organelle Ca2+ Cross-Talk. Mol Ther Nucleic Acids. 2020 Mar 6;19:1343-1356. doi: 10.1016/j.omtn.2020.01.017. Epub 2020 Jan 23. PMID: 32160705; PMCID: PMC7036712.
      研选
      AAV病毒包装
      询价